{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:09:59Z","timestamp":1779340199683,"version":"3.51.4"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031928","name":"Affiliated Hospital of Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kidney transplantation (KT) improves survival in end-stage renal disease, but long-term outcomes are undermined by antibody-mediated rejection (ABMR) and metabolic complications. Recent insights suggest a mechanistic interplay between immune injury and metabolic dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This narrative review synthesizes current literature on the pathogenesis and clinical impact of antibody-mediated rejection (ABMR), the epidemiology of post-transplant metabolic syndrome\u2014including post-transplant diabetes mellitus, dyslipidemia, and hypertension\u2014and their bidirectional relationship. Emerging diagnostic tools and therapeutic strategies are also examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ABMR remains a leading cause of late graft failure. Concurrently, 30% ~ 50% of KT recipients develop metabolic syndromes within the first year, driven by immunosuppressive agents and underlying risk factors. Metabolic abnormalities enhance endothelial activation and complement-driven inflammation, aggravating ABMR. Conversely, immunosuppressive intensification to treat ABMR worsens metabolic profiles, forming a vicious cycle. Novel immunologic (e.g., complement inhibitors, anti-CD38 antibodies) and metabolic (e.g., SGLT2 inhibitors, GLP-1 receptor agonists) agents show promise, though data on long-term efficacy remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integrated immunometabolic strategies are essential for optimizing graft and patient survival. Future research should focus on personalizing immunosuppression and targeting metabolic health to break the feedback loop linking ABMR and metabolic disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1826005","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:39:27Z","timestamp":1779338367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysregulation and antibody-mediated rejection after kidney transplantation: interacting mechanisms and emerging clinical strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Qizhen","family":"Yang","sequence":"first","affiliation":[{"name":"Organ Transplantation Department, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Tang","sequence":"additional","affiliation":[{"name":"Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Organ Transplantation Department, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Niu","sequence":"additional","affiliation":[{"name":"Organ Transplantation Department, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14702","article-title":"An economic assessment of contemporary kidney transplant practice","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/jpm13121706","article-title":"Adverse drug events after kidney transplantation","volume":"13","author":"Rostaing","year":"2023","journal-title":"J Personalized Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14062101","article-title":"Kidney transplant: More than immunological problems","volume":"14","author":"Gelpi","year":"2025","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.23876\/j.krcp.21.185","article-title":"The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort","volume":"41","author":"Jeon","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154916","article-title":"Emerging therapies for antibody-mediated rejection in kidney transplantation","volume":"12","author":"Abuazzam","year":"2023","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v6.i1.125","article-title":"Post-transplant dyslipidemia: mechanisms, diagnosis and management","volume":"6","author":"Agarwal","year":"2016","journal-title":"World J Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04084.x","article-title":"Dyslipidemia and its therapeutic challenges in renal transplantation","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad115","article-title":"Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study","volume":"38","author":"Lee","year":"2023","journal-title":"Nephrol Dialysis Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s13300-020-00790-5","article-title":"Post-transplantation diabetes mellitus","volume":"11","author":"Ahmed","year":"2020","journal-title":"Diabetes Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005187","article-title":"Chronic rejection after kidney transplantation","volume":"109","author":"Diebold","year":"2025","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1580369","article-title":"Novel insights and an updated review of metabolic syndrome in immune-mediated organ transplant rejection","volume":"16","author":"Tao","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082810","article-title":"Complement in antibody-mediated rejection of the kidney graft: From pathophysiology to clinical practice","volume":"14","author":"Sorohan","year":"2025","journal-title":"J Clin Med"},{"key":"B14","article-title":"The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell\u2013mediated rejection, antibody\u2010mediated rejection, and prospects for integrative endpoints for next\u2010generation clinical trials","volume-title":"Wiley online library","author":"Haas","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2024.01.021","article-title":"The effect of induction therapy on antibody-mediated rejection in kidney transplantation: a network meta-analysis using recent data","volume":"56","author":"Lee","year":"2024","journal-title":"Transplant Proc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718122","article-title":"Histopathologic features of antibody mediated rejection: the Banff classification and beyond","volume":"12","author":"Cornell","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7\u2013","DOI":"10.1038\/s41581-024-00912-3","article-title":"Consequence of microvascular inflammation in transplantation","volume":"21","author":"Allison","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v15.i1.99220","article-title":"Expanding role of antibodies in kidney transplantation","volume":"15","author":"Abbas","year":"2025","journal-title":"World J Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071506","article-title":"Non-HLA antibodies in kidney transplantation: immunity and genetic insights","volume":"10","author":"Sorohan","year":"2022","journal-title":"Biomedicines"},{"key":"B23","article-title":"Role of natural killer cells in antibody-mediated rejection of kidney transplantation","author":"Zhao","year":"2024","journal-title":"Altern Therapies Health Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/TP.0000000000004339","article-title":"Diagnostic potential of minimally invasive biomarkers: a biopsy-centered viewpoint from the Banff Minimally Invasive Diagnostics Working Group","volume":"107","author":"Huang","year":"2023","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf108","article-title":"Targeting IL-6 in antibody-mediated kidney transplant rejection","volume":"18","author":"Kanbay","year":"2025","journal-title":"Clin Kidney J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.541","article-title":"Recent advances in new-onset diabetes mellitus after kidney transplantation","volume":"12","author":"Montada-Atin","year":"2021","journal-title":"World J Diabetes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ph17080987","article-title":"Managing post-transplant diabetes mellitus after kidney transplantation: challenges and advances in treatment","volume":"17","author":"Rudzki","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02253-w","article-title":"Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis","volume":"61","author":"Du","year":"2024","journal-title":"Acta Diabetol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11370","article-title":"Influence of early postoperative basal insulin treatment and post-transplant diabetes mellitus risk on health-related quality of life in kidney transplant recipients\u2014An analysis of data from a randomized controlled trial","volume":"36","author":"Odler","year":"2023","journal-title":"Transplant Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post\u2010transplant diabetes: immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transplant Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ckj\/sfab131","article-title":"Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics","volume":"15","author":"Montero","year":"2022","journal-title":"Clin Kidney J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000951","article-title":"Efficacy, mechanisms, and safety of sodium-glucose cotransporter-2 inhibitors in kidney transplant recipients: a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Sridhar","year":"2026","journal-title":"Clin J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005496","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists in kidney transplantation: a systematic review and meta-analysis","volume":"110","author":"Lee","year":"2026","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12944-024-02276-w","article-title":"Efficacy and safety of statin therapy in kidney transplant recipients: a systematic review and meta-analysis","volume":"23","author":"Bellos","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/transplantology3020020","article-title":"Dyslipidemia in renal transplant recipients","volume":"3","author":"Chmielnicka","year":"2022","journal-title":"Transplantology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144080","article-title":"Dyslipidemia in transplant patients: which therapy","volume":"11","author":"Iannuzzo","year":"2022","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12882-024-03504-2","article-title":"Management of kidney transplant recipients for primary care practitioners","volume":"25","author":"Alotaibi","year":"2024","journal-title":"BMC Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16566","article-title":"The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients","volume":"21","author":"Lees","year":"2021","journal-title":"Am J Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.12.004","article-title":"Blood pressure goals and outcomes in kidney transplant recipients in an analysis of the collaborative transplant study","volume":"10","author":"Speer","year":"2025","journal-title":"Kidney Int Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.12574","article-title":"Impact of blood pressure on allograft function and survival in kidney transplant recipients","volume":"37","author":"Kim","year":"2024","journal-title":"Transplant Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.62716\/kn.000232025","article-title":"Blood pressure goals in kidney transplant recipients: more progress, but a target remains elusive","volume":"71","author":"Cathain","year":"2018","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-81292-7","volume-title":"Blood pressure disorders in acute and chronic kidney diseases","author":"Berbari","year":"2025"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1185001","article-title":"Uncontrolled hypertension is associated with increased risk of graft failure in kidney transplant recipients: a nationwide population-based study","volume":"10","author":"Kim","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B46","article-title":"Post kidney transplant: hypertension","volume-title":"Kidney transplant management: A guide to evaluation and comorbidities","author":"Patney","year":"2018"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-81292-7_6","article-title":"Post-kidney transplantation hypertension","volume-title":"Blood pressure disorders in acute and chronic kidney diseases","author":"Roumeliotis","year":"2025"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ckj\/sfab151","article-title":"The assessment of hypertension in kidney transplant patients: time to change our approach","volume":"15","author":"Demiray","year":"2022","journal-title":"Clin Kidney J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ckj\/sfab135","article-title":"Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis","volume":"15","author":"Pisano","year":"2022","journal-title":"Clin Kidney J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2009.01194","article-title":"Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients","volume":"24","author":"Luan","year":"2010","journal-title":"Clin Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v15.i1.97458","article-title":"Endothelial dysfunction in the kidney transplant population: current evidence and management strategies","volume":"15","author":"Prabhahar","year":"2025","journal-title":"World J Transplant"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-76","article-title":"Diet-induced increase in plasma oxidized LDL promotes early fibrosis in a renal porcine auto-transplantation model","volume":"12","author":"Chatauret","year":"2014","journal-title":"J Transl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf206","article-title":"Complement activation in kidney transplantation","volume":"41","author":"Kanbay","year":"2025","journal-title":"Nephrol Dialysis Transplant"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2024.100889","article-title":"Early and late antibody mediated rejection: Which game is the complement playing","volume":"39","author":"Delsante","year":"2025","journal-title":"Transplant Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2024.106876","article-title":"Role of leptin and adiponectin in the pathogenesis of post-transplant diabetes mellitus","volume":"174","author":"Szumilas","year":"2024","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061821","article-title":"Maintenance immunosuppression in kidney transplantation: a review of the current status and future directions","volume":"14","author":"Khan","year":"2025","journal-title":"J Clin Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.07.009","article-title":"Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE\/RAGE\/ILK pathway","volume":"99","author":"Liu","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.02.008","article-title":"Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction","volume":"43","author":"Hartog","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3869","article-title":"Critical protection from renal ischemia reperfusion injury by CD55 and CD59","volume":"172","author":"Yamada","year":"2004","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v15.i4.108806","article-title":"Critical role of complement in antibody mediated rejection in kidney transplantation","volume":"15","author":"Abbas","year":"2025","journal-title":"World J Transplant"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/oxygen5040020","article-title":"Oxidative stress score as an indicator of pathophysiological mechanisms underlying cardiovascular disease in kidney transplant recipients","volume":"5","author":"Gemma","year":"2025","journal-title":"Oxygen"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000275","article-title":"Prevention and treatment of liver allograft antibody-mediated rejection and the role of the \u2018two-hit hypothesis\u2019","volume":"21","author":"Kim","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"B63","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ajt.14974","article-title":"Gut microbiota dysbiosis and diarrhea in kidney transplant recipients","volume":"19","author":"Lee","year":"2019","journal-title":"Am J Transplant"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01626-24","article-title":"Gut microbiome and metabolome profiles in renal allograft rejection from multiomics integration","volume":"10","author":"Dai","year":"2025","journal-title":"MSystems"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14228032","article-title":"Distinct gut microbiome signatures in hemodialysis and kidney transplant populations","volume":"14","author":"Voroneanu","year":"2025","journal-title":"J Clin Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"44709","DOI":"10.1038\/s41598-025-28725-9","article-title":"Gut microbiome and metabolite signatures for predicting acute kidney transplant rejection: a prospective study","volume":"15","author":"Cho","year":"2025","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13672","article-title":"Effect of gut flora mediated\u2010bile acid metabolism on intestinal immune microenvironment","volume":"170","author":"Zhang","year":"2023","journal-title":"Immunology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13099-025-00705-4","article-title":"Fecal microbiota transplantation alleviates immunosuppressant-associated diarrhea and recurrent urinary tract infection in kidney transplant recipients: a retrospective analysis","volume":"17","author":"Hu","year":"2025","journal-title":"Gut Pathog"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00874-6","article-title":"CD38\u2014A new target in renal immune disease","volume":"20","author":"Rabelink","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B71","first-page":"e21477","article-title":"Administration of sodium-glucose cotransporter-2 inhibitors in kidney transplant patients with diabetes: a systematic review and meta-analysis","author":"Khodabandeh","year":"2023"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-007-0077-4","article-title":"Is RAS blockade routinely indicated in hypertensive kidney transplant patients","volume":"9","author":"Salzberg","year":"2007","journal-title":"Curr Hypertension Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"S413","DOI":"10.1016\/j.ajt.2025.07.948","article-title":"Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in kidney transplant recipients","volume":"25","author":"Kreitler","year":"2025","journal-title":"Am J Transplant"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101627","article-title":"Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus","volume":"51","author":"Cohen","year":"2025","journal-title":"Diabetes Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.12688\/f1000research.162502.1","article-title":"The efficacy and safety of SGLT2 inhibitors in diabetes kidney transplant recipients: a systematic review and meta-analysis","volume":"14","author":"Boonpiraks","year":"2025","journal-title":"F1000Research"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e97193","DOI":"10.7759\/cureus.97193","article-title":"Expanding the therapeutic landscape: Sodium-glucose co-transporter 2 inhibitors in kidney transplant recipients","volume":"17","author":"Khan","year":"2025","journal-title":"Cureus"},{"key":"B77","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ekir.2025.01.007","article-title":"Is it time to expand the use of SGLT2 inhibitors in kidney transplant recipients","volume":"10","author":"Giri","year":"2025","journal-title":"Kidney Int Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2337\/db25-729-P","article-title":"729-P: Retrospective effects of GLP-1 receptor agonists with and without concomitant SGLT2 inhibitor use in diabetic renal transplant recipients after 12 months","volume":"74","author":"Acosta","year":"2025","journal-title":"Diabetes"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf199","article-title":"GLP-1 receptor agonists for kidney transplant recipients","volume":"41","author":"Schmitz","year":"2026","journal-title":"Nephrol Dialysis Transplant"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1584612","article-title":"Efficacy and safety of different proprotein convertase subtilisin\/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis","volume":"16","author":"Luo","year":"2025","journal-title":"Front Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2604881","article-title":"PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients","volume":"47","author":"Luo","year":"2025","journal-title":"Renal Failure"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199664","article-title":"Apolipoproteins in chronic kidney disease and kidney transplant: a long unfinished story","volume":"26","author":"Secondulfo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/ds25-0031","article-title":"Impact of glucagon-like peptide 1 receptor agonists on tacrolimus dose-to-concentration ratios in solid organ transplantation","volume":"38","author":"Sweiss","year":"2025","journal-title":"Diabetes Spectr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:40:01Z","timestamp":1779338401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1826005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2026.1826005"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1826005","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1826005"}}